TY  - CONF

T1  - Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial

JO  - BONE

PY  - 2011/01/01

AU  - Brown J

AU  - Carducci M

AU  - Fizazi K

AU  - Smith M

AU  - Damiao DR

AU  - Karsh L

AU  - Milecki P

AU  - Wang H

AU  - Dansey R

AU  - Goessl C

ED  - 

DO  - DOI: 10.1016/j.bone.2010.10.042

VL  - 48

IS  - 1

SP  - S16

EP  - S16

Y2  - 2024/09/19

ER  -